Company Filing History:
Years Active: 2024-2025
Title: Johanna Kaarina Rokka: Innovator in HDAC6 Inhibitors
Introduction
Johanna Kaarina Rokka is a prominent inventor based in Boston, MA. She has made significant contributions to the field of biochemistry, particularly in the development of compounds that target histone deacetylase enzymes.
Latest Patents
Johanna holds a patent for HDAC6 inhibitors and imaging agents. This patent includes compounds that are useful for binding to one or more histone deacetylase enzymes (HDACs). The application also provides radiolabeled compounds that serve as radiotracers for positron emission tomography imaging of HDAC. Additionally, it outlines methods for preparing unlabeled and labeled compounds, diagnostic methods, and treatment methods for diseases associated with HDAC.
Career Highlights
Johanna is affiliated with The General Hospital Corporation, where she continues to advance her research and innovations. Her work has garnered attention for its potential applications in medical diagnostics and therapeutics.
Collaborations
Johanna has collaborated with notable colleagues, including Jacob Matthew Hooker and Changning Wang, enhancing the impact of her research through teamwork and shared expertise.
Conclusion
Johanna Kaarina Rokka is a trailblazer in the field of HDAC6 inhibitors, with her innovative work paving the way for advancements in medical imaging and treatment. Her contributions are vital to the ongoing research in this important area of biochemistry.